Human platelet alloantigen (HPA)-5a/b mismatch decreases disease-free survival in unrelated bone marrow transplantation

Tissue Antigens. 1999 Sep;54(3):229-34. doi: 10.1034/j.1399-0039.1999.540303.x.

Abstract

Matching of human platelet alloantigen (HPA) systems 2-6 was retrospectively investigated in 715 unrelated bone marrow transplantations. Of the five HPA systems studied, HPA-5 mismatching was found to have a significant effect on the disease-free survival rate of recipients following transplantation in the HLA-A, -B, -C, and -DR allele-matched donor-recipient pairs. The effect of the HPA-5 mismatch was most significant in the recipient group possessing the HLA haplotype A*2402-B*5201, which is a highly frequent haplotype among the Japanese population. However, the probability of development of acute graft-versus-host disease (GVHD) was not increased significantly by the HPA-5 mismatching. These findings suggest that the HPA-5 mismatching decreases the recipient's survival by a mechanism different from that in the case of mismatching of minor antigens found often in transplant recipients developing GVHD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Human Platelet / genetics*
  • Bone Marrow Transplantation / immunology*
  • Bone Marrow Transplantation / mortality
  • Disease-Free Survival
  • Epitopes / genetics
  • Genotype
  • Histocompatibility Testing* / methods
  • Humans
  • Leukemia / therapy
  • Minor Histocompatibility Antigens / genetics*
  • Retrospective Studies
  • Time Factors

Substances

  • 5a alloantigen, human
  • 5b alloantigen, human
  • Antigens, Human Platelet
  • Epitopes
  • Minor Histocompatibility Antigens